Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats
Open Access
- 6 November 2012
- journal article
- Published by Wiley in ISRN Oncology
- Vol. 2012, 1-7
Abstract
Introduction. Nephrotoxicity is one the side effect of cisplatin therapy and erythropoietin has been candidate as a nephroprotectant agent. However, its nephroprotective effect when it is accompained with estrogen has not been studied in female. Methods. 27 ovariectomized female Wistar rats divided into five groups. Groups 1 & 2 received estradiol valerate (0.5 mg/kg/week) for four weeks, and single dose of cisplatin (7 mg/kg, ip) was administrated at the end of week 3. Then the group 1 was treated with erythropoietin (100 U/kg/day), and the group 2 received vehicle during week 4. Groups 3 and 4 were treated similar to group 1 and 2, except for placebo instead estradiol valerate. Group5 (negative control) received placebo during the study. Animals were killed at the end of week 4. Results. In non-erythropoietin treated rats, cisplatin significantly increased the serum levels of blood urea nitrogen and creatinine (). However, these biomarkers significantly decreased by erythropoietin (). The weight loss, kidney weight, and kidney tissue damage score in rats treated with cisplatin but without estradiol were significantly less than the values in similar group when estradiol was present (). Conclusion. It seems that erythropoietin could protect the kidney against cisplatin-induced nephrotoxicity. This protective effect was not observed when estrogen was present.
Keywords
Funding Information
- Isfahan University of Medical Sciences
This publication has 41 references indexed in Scilit:
- Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apoptosisJournal Of Nephrology, 2012
- Protective effect of erythropoietin against cisplatin-induced nephrotoxicity in rats: antigenotoxic and antiapoptotic effectDrug and Chemical Toxicology, 2011
- Erythropoietin (EPO) in acute kidney injuryAnnals of Intensive Care, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Epoetin Delta as an Antifibrotic Agent in the Remnant Kidney Rat: A Possible Role for Transforming Growth Factor Beta and Hepatocyte Growth FactorNephron Experimental Nephrology, 2010
- Erythropoietin Protects Against Acute Kidney Injury and FailureThe Open Drug Discovery Journal, 2010
- Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cellsThe Journal of Gene Medicine, 2008
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- Erythropoietin protects against ischaemic acute renal injuryNephrology Dialysis Transplantation, 2004
- 2-Hydroxy-4-glutathion-S-yl-17beta-estradiol and 2-hydroxy-1-glutathion- S-yl-17beta-estradiol produce oxidative stress and renal toxicity in an animal model of 17beta-estradiol-mediated nephrocarcinogenicityCarcinogenesis, 1998